Technical Analysis for ABMD - ABIOMED, Inc.

Grade Last Price % Change Price Change
grade A 174.62 1.40% 2.41
ABMD closed up 1.4 percent on Friday, October 20, 2017, on 75 percent of normal volume. The bulls were able to push the stock to a new 52-week high.

Earnings due: Oct 26

Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical ABMD trend table...

Date Alert Name Type % Chg
Oct 20 New 52 Week High Other 0.00%
Oct 20 Three Weeks Tight Range Contraction 0.00%
Oct 16 MACD Bearish Signal Line Cross Bearish 2.39%
Oct 12 Hammer Candlestick Bullish 0.94%
Oct 12 1,2,3 Pullback Bullish Bullish Swing Setup 0.94%

Older signals for ABMD ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Its products consist of Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; Impella CP, a micro heart pump; and Impella 5.0 catheter and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite. The company also manufactures and sells the Impella RP, a percutaneous catheter-based axial flow pump; and AB5000 circulatory support system and the BVS 5000 biventricular support system for temporary support of acute heart failure patients in profound shock, including patients suffering from cardiogenic shock after a heart attack, post-cardiotomy cardiogenic shock, or myocarditis. In addition, it offers Symphony, a synchronized minimally invasive implantable cardiac assist device designed to treat chronic patients with moderate heart failure by improving patient hemodynamics; and AbioCor implantable replacement heart. The company sells its products through direct sales and clinical support personnel in the United States, Canada, Germany, France, the United Kingdom, and internationally. ABIOMED, Inc. was founded in 1981 and is headquartered in Danvers, Massachusetts.
Is ABMD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 175.71
52 Week Low 95.14
Average Volume 280,582
200-Day Moving Average 137.1219
50-Day Moving Average 160.504
20-Day Moving Average 170.147
10-Day Moving Average 172.848
Average True Range 2.9038
ADX 32.61
+DI 32.64
-DI 16.85
Chandelier Exit (Long, 3 ATRs ) 167.0786
Chandelier Exit (Short, 3 ATRs ) 167.0714
Upper Bollinger Band 179.2931
Lower Bollinger Band 161.0009
Percent B (%b) 0.74
BandWidth 10.750821
MACD Line 3.9119
MACD Signal Line 4.3101
MACD Histogram -0.3982
Fundamentals Value
Market Cap 7.7 Billion
Num Shares 44.1 Million
EPS 1.71
Price-to-Earnings (P/E) Ratio 102.12
Price-to-Sales 16.13
Price-to-Book 13.50
PEG Ratio 2.77
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 179.90
Resistance 3 (R3) 179.70 177.75 179.02
Resistance 2 (R2) 177.75 176.40 177.85 178.73
Resistance 1 (R1) 176.18 175.57 176.97 176.38 178.43
Pivot Point 174.23 174.23 174.62 174.33 174.23
Support 1 (S1) 172.66 172.88 173.45 172.86 170.81
Support 2 (S2) 170.71 172.05 170.81 170.51
Support 3 (S3) 169.14 170.71 170.22
Support 4 (S4) 169.34